1. Home
  2. JVA vs APVO Comparison

JVA vs APVO Comparison

Compare JVA & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.72

Market Cap

21.0M

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$1.37

Market Cap

21.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
APVO
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
21.7M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
APVO
Price
$3.72
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.4K
751.7K
Earning Date
09-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
64.91
N/A
EPS
0.32
N/A
Revenue
$89,748,681.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.45
N/A
Revenue Growth
17.92
N/A
52 Week Low
$2.75
$1.04
52 Week High
$9.93
$298.00

Technical Indicators

Market Signals
Indicator
JVA
APVO
Relative Strength Index (RSI) 42.48 49.24
Support Level $3.32 $1.04
Resistance Level $3.84 $1.54
Average True Range (ATR) 0.25 0.09
MACD 0.01 0.00
Stochastic Oscillator 45.18 63.46

Price Performance

Historical Comparison
JVA
APVO

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: